1. Home
  2. GLAD vs SVRA Comparison

GLAD vs SVRA Comparison

Compare GLAD & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Capital Corporation

GLAD

Gladstone Capital Corporation

HOLD

Current Price

$21.44

Market Cap

482.1M

Sector

Finance

ML Signal

HOLD

SVRA

Savara Inc.

HOLD

Current Price

$6.95

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLAD
SVRA
Founded
2001
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
482.1M
1.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GLAD
SVRA
Price
$21.44
$6.95
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
$22.33
$6.88
AVG Volume (30 Days)
196.4K
3.0M
Earning Date
11-17-2025
11-12-2025
Dividend Yield
9.23%
N/A
EPS Growth
N/A
N/A
EPS
2.55
N/A
Revenue
$89,122,000.00
N/A
Revenue This Year
$13.04
N/A
Revenue Next Year
$9.55
N/A
P/E Ratio
$8.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.76
$1.89
52 Week High
$30.43
$7.00

Technical Indicators

Market Signals
Indicator
GLAD
SVRA
Relative Strength Index (RSI) 66.47 81.34
Support Level $21.27 $5.55
Resistance Level $21.60 $6.78
Average True Range (ATR) 0.33 0.45
MACD 0.08 0.09
Stochastic Oscillator 82.11 98.10

Price Performance

Historical Comparison
GLAD
SVRA

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: